Please login to the form below

CEO

This page shows the latest CEO news and features for those working in and with pharma, biotech and healthcare.

Cohen in early 2017 – the company’s former CEO Joe Jimenez (pictured below) had multiple discussions in the following months.

May’s Brexit plan cautiously welcomed by biopharma sector

health, ”say ABPI chief executive Mike Thompson and BIA CEO Steve Bates in a joint statement.
Daily Brief: Trump arrives in London, NICE says no to Darzalex, Pfizer backs down on prices

Pfizer backs down on prices increases. Pfizer backed down yesterday on the US price rises it recently announced after President Trump had an ‘extensive discussion’with its CEO Ian Read.
Christina Coughlin to leave Immunocore for Tmunity

The departure of Coughlin will be another loss for Immunocore, meanwhile, as it CEO Eliot Forster left the company in February.
Fishawack acquires brand communications agency Healthcircle

David Ingram, Healthcircle Managing Partner; Front row: Mike Taylor, Healthcircle Managing Director, Oliver Dennis, Fishawack CEO.
Pfizer builds gap between pharma and consumer health units

Pfizer CEO described the move as a “natural evolution”for the group as it looks to life beyond 2020 – after which it will have dealt with most of its ‘patent cliff’–

More from news
Approximately 3 fully matching, plus 1,124 partially matching documents found.

The rise of vertical integration in the US payer landscape

During a CNBC interview Cigna CEO David Cordani emphasised this acquisition would “[improve] affordability and personalization for customers and clients, and [drive] more choice, great alignment with healthcare professionals, and more
Diversity and inclusion in the pharma industry

Jodie Morrison, CEO of Tokai Pharmaceuticals and Robert K Coughlin, President and CEO of MassBio, in a recent article on GPG in STAT, summed up why it is important: ‘The global ... If, as GlaxoSmithKline CEO Emma Walmsley said, talking about diversity
Is flexible working the future?

Wiles, the founder and former joint CEO of Virgo Health, who is set to celebrate the first anniversary of the Collective in June, says: “We are proof that the communications industry
‘How is your day?’

Jan M Bult is President and CEO of the Plasma Protein Therapeutics Association, the organisation charged with building global awareness of plasma protein therapies.
The playbook of a ‘reluctant creative’

David Youds is CEO at Bedrock Healthcare Communications.

More from intelligence
Approximately 0 fully matching, plus 146 partially matching documents found.

Medicen Paris Region appoints new CEO

Medicen Paris Region appoints new CEO. Stéphana Roques joins the European health cluster.
Axovant poaches Allergan’s and Teva’s chief medical and science officers

Pavan Cheruvu, chief executive officer, Axovant, said: “Since starting as CEO in February, I have been focused on transforming Axovant into a leaner organisation, introducing heightened standards of quality and excellence
Lars Rebien Sørensen becomes chairman of Novo Holdings

Former Novo Nordisk CEO Lars Rebien Sørensen has been appointed as Novo Holdings’new chairman.
Neurimmune appoints chief business officer

Roger Nitsch, president and CEO of Neurimmune, said: “We are pleased that Dr Buller joins our company to further drive our growth strategy.
PropPharma selects new CEO and president

PropPharma selects new CEO and president. Dawn Sherman takes up the roles effective 14 May. ... Sherman succeeds Jeff Hargroves, founder and CEO of ProPharma group, who will continue to be an active member of the board.

More from appointments
Approximately 0 fully matching, plus 650 partially matching documents found.

Trio of Communiqué Awards for Havas Lynx

David Hunt, Havas Lynx CEO, was delighted with the outcome: “ The Communiqué Awards are highly regarded in the Healthcare Communications world so to win one award is some achievement… to win
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills

Katrine Bach, CEO, Anthill Agency:“ Pharma needs to accelerate its digital adoption and, while we can learn a lot from outside the industry, pharma is unique. ... Alexandre Dauge, CEO, Actando:“ One of the great benefits of the open-source platform
90TEN’s life changing PR and medical education campaigns shortlisted for five Communiqué Awards

Carole North, CEO at 90TEN said: “ To make a difference through healthcare communications it’ s essential to stand out from the crowd.
Random42 appoints Bill Collis as Chairman

Previously, Bill has served as CEO and President of The Foundry, where he led over a decade of change and innovation, transforming a niche London-based visual effects software company into ... Random42 CEO and Medical Director, Ben Ramsbottom, commented
How will new data protection law affect pharma?

It is important for companies to ensure they have a nominated data protection officer – in a smaller company this will be the CEO or equivalent.